drugset / Trial / NCT01174953

High Risk Prostate Cancer Prevention Study

NCT01174953

Completed 18 enrolled University of Kansas
NaSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to study the molecular effects of the chemopreventative agent, finasteride, in combination with dietary soy supplementation in patients at high risk for the development of prostate cancer. Also, the investigators intend to create a large database with health information from men who are at high risk of developing prostate cancer, along with serum and tissue samples from those patients who are willing to provide tissue and serum samples.

Timeline

Start
2010-07
Primary completion
2013-03
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Finasteride Small molecule 5 mg
Subject Soy Unknown 160 mg

Indications